首页> 外国专利> Enteropeptidase boropeptide inhibitors and their uses in treatments of obesity, overweight and / or diseases associated with an abnormal fat metabolism

Enteropeptidase boropeptide inhibitors and their uses in treatments of obesity, overweight and / or diseases associated with an abnormal fat metabolism

机译:肠肽酶boropeptide抑制剂及其在肥胖,超重和/或与脂肪代谢异常有关的疾病的治疗中的用途

摘要

A compound selected from the group consisting of Glu-Gly-Boro-Arg, Ala-Phe-Boro-Arg, Ac-Glu-Gly-Boro-Arg, and Ac-Ala-Phe-Boro-Arg, where Ac is acetyl .
机译:选自Glu-Gly-Boro-Arg,Ala-Phe-Boro-Arg,Ac-Glu-Gly-Boro-Arg和Ac-Ala-Phe-Boro-Arg的化合物,其中Ac是乙酰基。

著录项

  • 公开/公告号ES2575131T3

    专利类型

  • 公开/公告日2016-06-24

    原文格式PDF

  • 申请/专利权人 OBE THERAPY BIOTECHNOLOGY;

    申请/专利号ES20080855879T

  • 发明设计人 HAROSH ITZIK;BRAUD SANDRINE;

    申请日2008-12-03

  • 分类号C07K5/06;A61K38;A61K38/05;A61K38/06;A61P3/04;C07K5/062;C07K5/065;C07K5/072;C07K5/08;C07K5/083;C07K5/087;C07K5/09;

  • 国家 ES

  • 入库时间 2022-08-21 14:22:12

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号